Scotiabank lowered the firm’s price target on Well Health (WHTCF) to C$6.50 from C$7 and keeps an Outperform rating on the shares.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on WHTCF:
- WELL Health Boosts Capital Firepower and Clinic Network With Alberta E‑Consult Acquisition
- WELL Health Doubles Credit Capacity and Buys Alberta E-Consult Platform to Accelerate Clinic Expansion
- WELL Health CEO Sets Out 2026 Strategic Priorities in Shareholder Letter
- WELL Health Technologies: Anticipated Re‑Rating as Temporary Overhangs Clear and Capital Rotates to Higher-Return Canadian Clinics
- Well Health downgraded to Speculative Buy from Buy at Cormark